0001569706-18-000003.txt : 20181106
0001569706-18-000003.hdr.sgml : 20181106
20181106173319
ACCESSION NUMBER: 0001569706-18-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181026
FILED AS OF DATE: 20181106
DATE AS OF CHANGE: 20181106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Averback Paul
CENTRAL INDEX KEY: 0001569706
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12033
FILM NUMBER: 181164073
MAIL ADDRESS:
STREET 1: C/O NYMOX PHARMACEUTICAL CORPORATION
STREET 2: 9900 CAVENDISH BLVD., SUITE 306
CITY: ST. LAURENT
STATE: A8
ZIP: H4M 2V2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP
CENTRAL INDEX KEY: 0001018735
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
BUSINESS PHONE: 1-800-936-9669
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-10-26
0
0001018735
NYMOX PHARMACEUTICAL CORP
NYMX
0001569706
Averback Paul
C/O NYMOX PHARMACEUTICAL CORPORATION
9900 CAVENDISH BLVD., SUITE 306
ST. LAURENT
A8
H4M 2V2
QUEBEC, CANADA
1
1
1
0
CEO
Restricted Common
2018-10-26
4
S
0
100000
1.75
D
23331448
D
Paul Averback
2018-11-06